Back
Apellis Pharmaceuticals Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
37
APLS
Apellis Pharmaceuticals
Last Price:
41.02
Seasonality Move:
5.93%
Sell
15
ALNY
Alnylam Pharmaceuticals
Last Price:
246.59
Seasonality Move:
6.72%
Sell
37
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $41.05. The Score for APLS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $246.78. The Score for ALNY is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $41.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $246.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.46 | Buy |
Relative Strength Index (14 RSI): | 60.14 | Buy |
Chaikin Money Flow: | 854085 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.92 - 39.7) | Buy |
Bollinger Bands (100): | (36.8 - 44.46) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.98 | Buy |
Relative Strength Index (14 RSI): | 39.94 | Sell |
Chaikin Money Flow: | -378372 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (258.04 - 277.96) | Sell |
Bollinger Bands (100): | (152.5 - 260.08) | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.04 | Buy |
20-day SMA: | 38.43 | Buy |
50-day SMA: | 37.98 | Buy |
200-day SMA: | 50.76 | Sell |
8-day EMA: | 39.27 | Buy |
20-day EMA: | 38.68 | Buy |
50-day EMA: | 39.03 | Buy |
200-day EMA: | 46.63 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 264.46 | Sell |
20-day SMA: | 268.49 | Sell |
50-day SMA: | 256.91 | Sell |
200-day SMA: | 187.09 | Buy |
8-day EMA: | 259.34 | Sell |
20-day EMA: | 263.1 | Sell |
50-day EMA: | 247.85 | Sell |
200-day EMA: | 202.56 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.24 per share, an increase this year of $3.17 per share, and an increase next year of $1.50 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
Apellis Pharmaceuticals Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |